Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass
NCT: NCT06861881 · NOT_YET_RECRUITING
Brief Summary
The purpose of this research study is to test the accuracy of the Dexcom continuous glucose monitoring device during the cardiothoracic surgical procedure and recovery period in the Cardiac Intensive Care Unit. Readings from the device will be compared with the standard of care blood glucose levels that are obtained during your surgery and postoperatively.
Frequently Asked Questions
What is Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass?
Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass is a clinical trial registered under NCT06861881. Current status: NOT_YET_RECRUITING.
What is the status of NCT06861881?
The current status of NCT06861881 (Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass) is: NOT_YET_RECRUITING.
When did Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass start?
Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.